Invited commentary: Influenza vaccine and guillain-barré syndrome-is there a risk?

Medicine & Life Sciences

• Influenza Vaccines 100%
• Human Influenza 64%
• Orthomyxoviridae Infections 50%
• H1N1 Subtype Influenza A Virus 44%
• Vaccines 39%
• Disease Outbreaks 31%
• Vaccination 28%
• Mass Vaccination 24%
• Influenza A virus 19%
• Mexico 18%
• Insurance Benefits 18%
• Centers for Disease Control and Prevention (U.S.) 18%
• Insurance 17%
• Epidemics 15%
• Population 13%
• Public Health 12%
• Viruses 11%
• Safety 10%
• Mortality 8%
• Infections 8%